Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer.

Theresa M Kuhn Sarfraz AhmadFernando O RecioAhmad AwadaNathalie D McKenzieJames E KendrickAndrew KellerRobert W Holloway

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

Neoadjuvant chemotherapy using combination platinum/paclitaxel/bevacizumab was efficacious for locally advanced vulvar cancer, resulting in complete resections, negative margins, and excellent wound healing. A multi-institutional phase II trial is warranted to validate these findings.

Keyphrases

neoadjuvant chemotherapy
sentinel lymph node
locally advanced
papillary thyroid
lymph node
squamous cell
wound healing
squamous cell carcinoma
metastatic colorectal cancer
early stage
radiation therapy
randomized controlled trial
lymph node metastasis
open label
clinical trial
childhood cancer
young adults